-

AgelessRx Enters Sleep Health Category, Underscoring Critical Role Sleep Plays in Healthspan and Lifespan

Leading longevity telehealth platform expands portfolio, adding personalized prescription and natural sleep treatment options to support health and well-being

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, today announced its entry into the sleep health category, building on its commitment to redefine aging and improve quality of life. With a strong emphasis on research-backed solutions, AgelessRx’s sleep program provides personalized sleep treatment plans, and two new products–prescription Trazodone and natural, over-the-counter (OTC) Tran-Q Sleep Supplement–alongside easy-to-adopt lifestyle recommendations. Guided by the latest scientific insights into sleep health, AgelessRx sleep regimens are effective, tailored to customers’ unique needs, and integrated into holistic, personalized treatment plans focused on extending lifespan and enhancing healthspan.

“The negative impacts of poor sleep outweigh any positive contributions proper diet and adequate exercise can offer. Our goal is to ensure this critical function is a core part of everyone's longevity routine.”

Share

Quality sleep is the cornerstone of cognitive and physical health, reducing the risk of chronic conditions like heart disease, diabetes, and obesity, which are linked to shorter lifespans. 1 in 3 Americans report sub-optimal sleep with the demands and distractions of modern lifestyles frequently deprioritizing rest and undermining sleep. AgelessRx’s tailored sleep solutions address this growing health crisis and are part of its ongoing mission to support the most important aspects of proactive healthcare.

"Advances in research and understanding of sleep architecture underscores the importance of sleep as a major determinant of health and longevity—it’s our health insurance,” said Dr. Sajad Zalzala, co-founder and chief medical officer of AgelessRx. “The negative impacts of poor sleep outweigh any positive contributions proper diet and adequate exercise can offer. Our goal is to ensure this critical function is a core part of everyone's longevity routine.”

Trazodone and Tran-Q Sleep

AgelessRx’s new offerings are oral, non-habit forming interventions that support all four pillars of sleep: quantity, quality, regularity, and timing. Trazodone is a prescription medication with well-researched use as a safe, effective sleep aid and Tran-Q Sleep is a natural, melatonin-free OTC supplement designed for relaxation and sleep support.

AgelessRx’s clinical team thoroughly reviews every patient’s medical history, unique needs, and health goals to determine the appropriate treatment for each individual. Together, these options serve a broad range of needs for people seeking improved sleep quality and sleep architecture—the process by which we cycle through different sleep stages.

  • Trazodone (Rx): Studies show that Trazodone is effective at improving sleep onset and reducing nighttime awakenings and that Trazodone lowers the volume of three key neurochemical systems associated with waking: serotonin, histamine, and noradrenaline. Trazodone is recognized as a well-tolerated long-term intervention that has few side effects, boosting deep sleep without impacting rapid eye movement (REM) sleep, and minimizing next-day drowsiness.
  • Tran-Q Sleep (OTC): Formulated with all-natural herbal ingredients, including passionflower and lavender, Tran-Q Sleep enhances the calming neurotransmitter (GABA) signaling and relaxes muscles while counter-balancing an overstimulated nervous system to gently prepare the mind and body for restful sleep. As a non-prescription option, Tran-Q Sleep caters to those seeking a natural solution for sleep improvement.

For additional information about AgelessRx and its sleep products and services, please visit agelessrx.com.

About AgelessRx

AgelessRx is at the forefront of the longevity revolution, offering clinically validated cutting-edge solutions and preventive treatments aimed at extending life expectancy and enhancing quality of life. AgelessRx also continues to advance the field of longevity science by conducting ongoing research and clinical trials. Through its online platform, AgelessRx provides easy access to innovative healthcare services, with an emphasis on customer satisfaction, affordability, and the pursuit of a future where extended healthspan is a reality for everyone. Follow AgelessRx on Instagram, X, and Facebook.

Contacts

Media contact:
JackTaylor PR
agelessrx@jacktaylorpr.com

AgelessRx


Release Versions

Contacts

Media contact:
JackTaylor PR
agelessrx@jacktaylorpr.com

Social Media Profiles
More News From AgelessRx

AgelessRx Launches Methylene Blue, Pioneering Accessible Cognitive Longevity Solutions

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, announces the launch of its newest offering: Methylene Blue capsules. Recent studies suggest that Methylene Blue may support focus, brain health, and cellular energy production, all in a mess-free, convenient capsule format. The launch of Methylene Blue marks AgelessRx’s launch into the cognitive health market valued at $11.55 billion in 2025 and projected to reach $40.27 billion by 2035. The global M...

AgelessRx Expands Offerings to Include Oral GLP-1 Drops to Advance Metabolic Health and Longevity Science

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a pioneer in longevity and telehealth solutions, announced the introduction of oral sublingual drops for GLP-1 receptor agonists Semaglutide and Tirzepatide. By offering non-injectable alternatives to medications that may support metabolic health management1 and counter the effects of aging2, AgelessRx continues to empower individuals to live longer, healthier lives. Optimal metabolic health is a foundational component of longevity. Dysregulated glu...

AgelessRx’s PEARL Trial Links Rapamycin Use to Healthspan Improvement

ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a leader in longevity telehealth solutions, announced the results of its 12-month, Participatory Evaluation of Aging with Rapamycin for Longevity (PEARL) clinical trial, the largest and longest decentralized, crowd-funded trial of its kind on Rapamycin safety for healthy aging in a normative aging population. The double-blind, randomized, placebo-controlled trial is also the first nationwide decentralized trial and the first large-scale intervention...
Back to Newsroom